A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia.
Phase of Trial: Phase II/III
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Eszopiclone (Primary) ; Zolpidem
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- 18 Jan 2012 Results were presented in an Eisai media release.
- 30 Nov 2010 A Marketing Authorization Application has been submitted in Japan based on the results from this study.
- 21 Sep 2010 Assumed completed; checked with ms1.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History